Beyond animal testing: The rise of organoids in toxicology research
Drug Discovery World
MARCH 20, 2024
billion for bringing a new drug to market, a process extending over a decade. They can be developed from both normal and diseased tissue and remain stable when expanded ex vivo in the lab, offering a distinct advantage for testing off-target and on-target toxicities within the same patient sample.
59 
Let's personalize your content